[Panel webinar] Creating a sustainable and resilient pharma supply from raw materials to the patient
Join the discussion to find out how pharma organizations are increasing their focus on data, analytics and visibility to drive sustainability, resilience and agility in the supply chain
Lessons in optimizing manufacturing and supply networks to create agility and flexibility to empower all stakeholders involved
The pharma industry is 55 per cent more emission-intensive than the automotive industry, according to the report titled, Carbon footprint of the global pharmaceutical industry and relative impact of its major players. At the same time regulators and society demand safe, affordable and accessible healthcare globally.
For pharma companies to improve their sustainability it is critical that they address the challenges facing their supply chain.
The best way to achieve this is by having a fully digital supply chain which gives visibility on the full value chain, thereby enabling pharma companies to enhance efficiency, resiliency, adjust routing and suppliers in real time and ensure quality throughout the process.
The current reality however is that for the majority of businesses the supply chain is still highly fragmented with no single digital threat throughout, inhibiting efforts to improve the end to end process.
With this in mind, join Dr Barbara Holtz, Expert Business Consultant, Life Sciences at Dassault Systèmes and the rest of our panel as they explore how to improve sustainability by transitioning from a fragmented to an integrated digital supply chain.
Specifically, this webinar will address:
- The sustainability of the current pharma supply chain
- The primary issues impacting sustainability within pharma
- Accessing data from across the supply chain to provide end to end visibility
- Enhancing the agility of the overall supply chain to improve resiliency
- Leveraging innovative technology such as AI and digital twins to enhance flexibility and effectiveness
Panelists:
Dr Barbara Holtz, Expert Business Consultant, Life Sciences at Dassault Systèmes
Barbara Holtz has been working in the life sciences industry for over 20 years, working with companies such as Bayer, GSK and AstraZeneca to help them improve their business processes through digitalization. A PhD physicist by training, Holtz uses her analytical skills to understand what drives the need to digitalize and focuses on manufacturing and sustainability for the pharmaceutical sector, working with companies across Europe.
Pietro Bertuzzi, Supply Chain Digital Twin Engineer, Bayer Consumer Health
Saurabh Verma, Director Value Chain Excellence, Janssen
This webinar will take place at:
- 3pm CET
- 9am EDT
- 6am PDT
Sponsored By: 
